Efficacy and Safety of Non-vitamin K Oral Anticoagulants and Vitamin K Oral Anticoagulants on Some Metabolic and Coagulation Parameters in Diabetic and Nondiabetic Patients With First Diagnosis of Non-valvular Atrial Fibrillation
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms ORGANON
- 08 Nov 2020 Status changed from recruiting to completed.
- 20 Oct 2016 New trial record